Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea

Infection and Immunity

Volumn 80, Issue 4, 2012, Pages 1323-1332

  Shima, Ayaka ^a   Hinenoya, Atsushi ^a   Asakura, Masahiro ^a   Sugimoto, Norihiko ^a   Tsukamoto, Teizo ^a,b   Ito, Hideaki ^a   Nagita, Akira ^c   Faruque, Shah M ^d   Yamasaki, Shinji ^a  

^a Osaka Prefecture University   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c Mizushima Central Hospital   (Japan)

^d INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOLETHAL DISTENDING TOXIN; CYTOLETHAL DISTENDING TOXIN A; CYTOLETHAL DISTENDING TOXIN B; CYTOLETHAL DISTENDING TOXIN C; HISTONE H2AX; RECOMBINANT PROTEIN; RECOMBINANT PROVIDENCIA ALCALIFACIENS CYTOLETHAL DISTENDING TOXIN PROTEIN; TRANSPOSASE; UNCLASSIFIED DRUG; BACTERIAL DNA; BACTERIAL TOXIN; HISTONE;

ALLELE; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DIARRHEA; DNA FLANKING REGION; ESCHERICHIA COLI; G2 PHASE CELL CYCLE CHECKPOINT; GENE CLUSTER; GENE LOCUS; GENE TRANSFER; HUMAN; HUMAN CELL; HYBRIDIZATION; M PHASE CELL CYCLE CHECKPOINT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROVIDENCIA; PROVIDENCIA ALCALIFACIENS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SHIGELLA BOYDII; ANIMAL; BACTERIAL GENE; CELL CYCLE CHECKPOINT; CELL LINE; CELL STRAIN 3T3; CELL STRAIN CACO 2; CERCOPITHECUS; CHEMISTRY; CHO CELL; DNA SEQUENCE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; HAMSTER; HELA CELL; HORIZONTAL GENE TRANSFER; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; PHOSPHORYLATION; PRESCHOOL CHILD; RABBIT; VERO CELL;

ANIMALS; BACTERIAL TOXINS; BASE SEQUENCE; CACO-2 CELLS; CELL CYCLE CHECKPOINTS; CELL LINE; CERCOPITHECUS AETHIOPS; CHILD; CHILD, PRESCHOOL; CHO CELLS; CRICETINAE; DIARRHEA; DNA, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HELA CELLS; HISTONES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PHOSPHORYLATION; PROVIDENCIA; RABBITS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SHIGELLA BOYDII; VERO CELLS;

EID: 84860793057     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05831-11     Document Type: Article

References (59)

1. Albert MJ, et al. 1992. Pathogenesis of Providencia alcalifaciens-induced diarrhea. Infect. Immun. 60:5017-5024.
2. Albert MJ, et al. 1996. Controlled study of cytolethal distending toxinproducing Escherichia coli infections in Bangladeshi children. J. Clin. Microbiol. 34:717-719.
3. Albert MJ, Faruque AS, Mahalanabis D. 1998. Association of Providencia alcalifaciens with diarrhea in children. J. Clin. Microbiol. 36:1433-1435.
4. Ansaruzzaman M, et al. 2000. Clonal groups of enteropathogenic Escherichia coli isolated in case-control studies of diarrhoea in Bangladesh. J. Med. Microbiol. 49:177-185.
5. Asakura M, et al. 2007. An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 104:14483- 14488.
6. Asakura M, et al. 2007. Comparative analysis of cytolethal distending toxin (cdt) genes among Campylobacter jejuni, C. coli, and C. fetus strains. Microb. Pathog. 42:174 -183.
7. Bielaszewska M, et al. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816.
8. Birnboim HC, Doly J. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
9. Bouzari S, Oloomi M, Oswald E. 2005. Detection of the cytolethal distending toxin locus cdtB among diarrheagenic Escherichia coli isolates from humans in Iran. Res. Microbiol. 156:137-144.
10. Burgos Y, Beutin L. 2010. Common origin of plasmid encoded alphahemolysin genes in Escherichia coli. BMC Microbiol. 10:193.
11. Carette JE, et al. 2009. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326:1231-1235.
12. Chen YT, et al. 2004. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337:189 -198.
13. Chlibek R, Jirous J, Beran J. 2002. Diarrhea outbreak among Czech Army Field Hospital personnel caused by Providencia alcalifaciens. J. Travel Med. 9:151-152.
14. Chouikha I, et al. 2006. A selC-associated genomic island of the extraintestinal avian pathogenic Escherichia coli strain BEN2908 is involved in carbohydrate uptake and virulence. J. Bacteriol. 188:977-987.
15. Elwell C, Chao K, Patel K, Dreyfus L. 2001. Escherichia coli CdtB medi-ates cytolethal distending toxin cell cycle arrest. Infect. Immun. 69:3418- 3422.
16. Eshraghi A, et al. 2010. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J. Biol. Chem. 285:18199 -18207.
17. Falkow S, Ryman IR, Washington O. 1962. Deoxyribonucleic acid base composition of Proteus and Providencia organism. J. Bacteriol. 83:1318- 1321.
18. Friedrich AW, et al. 2006. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 44:1844 -1846.
19. Fu JF, Chang HC, Chen YM, Chang YS, Liu ST. 1995. Sequence analysis of an Erwinia stewartii plasmid, pSW100. Plasmid 34:75- 84.
20. Ghilardi AC, Gomes TA, Trabulsi LR. 2001. Production of cytolethal distending toxin and other virulence characteristics of Escherichia coli strains of serogroup O86. Mem. Inst. Oswaldo Cruz 96:703-708.
21. Guth BEC, Perrella E. 1996. Prevalence of invasive ability and other virulence-associated characteristics in Providencia alcalifaciens strains isolated in Sao Paulo, Brazil. J. Med. Microbiol. 45:459-462.
22. Haynes J, Hawkey PM. 1989. Providencia alcalifaciens and traveller's diarrhoea. BMJ 299:94 -95.
23. Hinenoya A, et al. 2007. Cytolethal distending toxin (Cdt)-producing Escherichia coli isolated from a child with bloody diarrhea in Japan. Microbiol. Immunol. 51:435- 438.
24. Hinenoya A, et al. 2009. Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan. Microbiol. Immunol. 53:206 -215.
25. Hyma KE, et al. 2005. Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains J. Bacteriol. 187:619-628.
26. Janda JM, Abbott SL, Woodward D, Khashe S. 1998. Invasion of HEp-2 and other eukaryotic cell lines by Providenciae: further evidence supporting the role of Providencia alcalifaciens in bacterial gastroenteritis. Curr. Microbiol. 37:159-165.
27. Janda JM, Abbott LS. 2006. The enterobacteria, 2nd ed, p 279-299. ASM Press, Washington, DC.
28. Janka A, et al. 2003. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634 -3638.
29. Johnson WM, Lior H. 1987. Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol. Lett. 43: 19-23.
30. Kaniga K, Uralil J, Bliska JB, Galán JE. 1996. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21:633- 641.
31. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. Lara-Tejero M, Galan JE. 2000. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290:354 -357.
33. Leslie A, McSweeney LA, Dreyfus LA. 2004. Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell. Microbiol. 6:447- 458.
34. Marques LR, Tavechio AT, Abe CM, Gomes TA. 2003. Search for cytolethal distending toxin production among fecal Escherichia coli isolates from Brazilian children with diarrhea and without diarrhea. J. Clin. Microbiol. 41:2206 -2208.
35. Mathan MM, Mathan VI, Albert MJ. 1993. Electron microscopic study of the attachment and penetration of rabbit intestinal epithelium by Providencia alcalifaciens. J. Pathol. 171:67-71.
36. Murata T, et al. 2001. A large outbreak of food-borne infection attributed to Providencia alcalifaciens. J. Infect. Dis. 184:1050 -1055.
37. Nesic D, Hsu Y, Stebbins CE. 2004. Assembly and function of a bacterial genotoxin. Nature 429:429-433.
38. Nougayrede JP, Taibe F, Rycke JD, Oswald E. 2005. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13:103-110.
39. Okeke IN, Lamikanra A, Steinruck H, Kaper JB. 2000. Characterization of Escherichia coli strains from cases of childhood diarrhea in provincial southwestern Nigeria. J. Clin. Microbiol. 38:7-12.
40. Okuda J, Fukumoto M, Takeda Y, Nishibuchi M. 1997. Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect. Immun. 65:428-433.
41. Pandey M, et al. 2003. Association of cytolethal distending toxin locus cdtB with enteropathogenic Escherichia coli isolated from patients with acute diarrhea in Calcutta, India. J. Clin. Microbiol. 41:5277-5281.
42. Pearson MM, et al. 2008. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190:4027- 4037.
43. Pérès SY, et al. 1997. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 24:1095-1107.
44. Petty NK, et al. 2010. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 192:525-538.
45. Pickett CL, Cottle DL, Pesci EC, Bikah G. 1994. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 62:1046 -1051.
46. Scott DA, Kaper JB. 1994. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 62:244 -251.
47. Sen R. 1962. Isolation of strains of Providencia group from cases with diarrhoea in Ibadan, Nigeria, West Africa. Indian J. Med. Res. 50:622- 626.
48. Sobreira M, Leal NC, Magalhães M, Guth BE, Almeida AM. 2001. Molecular analysis of clinical isolates of Providencia alcalifaciens. J. Med. Microbiol. 50:29-34.
49. Stabler RA, et al. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10:R102.
50. Tóth I, Herault F, Beutin L, Oswald E. 2003. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J. Clin. Microbiol. 41:4285-4291.
51. Tóth I, et al. 2009. Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect. Immun. 77:492-500.
52. Uesaka Y, et al. 1994. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb. Pathog. 16:71-76.
53. Williamson VM, Kaya HK. 2003. Sequence of a symbiont. Nat. Biotechnol. 21:1294-1295.
54. Wising C, Molne L, Jonsson IM, Ahlman K, Lagergard T. 2005. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid. Microbes Infect. 7:867- 874.
55. Yamasaki S, et al. 2006. Cytolethal distending toxin (CDT): genetic diversity, structure and role in diarrheal disease. Toxin Rev. 25:61- 88.
56. Yoh M, et al. 2005. Importance of Providencia species as a major cause of travellers' diarrhoea. J. Med. Microbiol. 54:1077-1082.
57. Young VB, et al. 2004. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 72:2521-2527.
58. Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.
59. Yu YS, Du XX, Zhou ZH, Chen YG, Li LJ. 2006. First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob. Agents Chemother. 50:1610 -1611.